Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients

Background: We aimed to identify two new prognostic subtypes and create a predictive index for prostate cancer (PCa) patients based on ferroptosis database. Methods: The nonnegative matrix factorization approach was used to identify molecular subtypes. We investigate the differences between cluster...

Full description

Bibliographic Details
Main Authors: Dechao Feng, Zhouting Tuo, Jie Wang, Luxia Ye, Dengxiong Li, Ruicheng Wu, Wuran Wei, Yubo Yang, Chi Zhang
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023107031
_version_ 1797337024270696448
author Dechao Feng
Zhouting Tuo
Jie Wang
Luxia Ye
Dengxiong Li
Ruicheng Wu
Wuran Wei
Yubo Yang
Chi Zhang
author_facet Dechao Feng
Zhouting Tuo
Jie Wang
Luxia Ye
Dengxiong Li
Ruicheng Wu
Wuran Wei
Yubo Yang
Chi Zhang
author_sort Dechao Feng
collection DOAJ
description Background: We aimed to identify two new prognostic subtypes and create a predictive index for prostate cancer (PCa) patients based on ferroptosis database. Methods: The nonnegative matrix factorization approach was used to identify molecular subtypes. We investigate the differences between cluster 1 and cluster 2 in terms of clinical features, functional pathways, tumour stemness, tumour heterogeneity, gene mutation and tumour immune microenvironment score after identifying the two molecular subtypes. Colony formation assay and flow cytometry assay were performed. Results: The stratification of two clusters was closely connected to BCR-free survival using the nonnegative matrix factorization method, which was validated in the other three datasets. Furthermore, multivariate Cox regression analysis revealed that this classification was an independent risk factor for patients with PCa. Ribosome, aminoacyl tRNA production, oxidative phosphorylation, and Parkinson's disease-related pathways were shown to be highly enriched in cluster 1. In comparison to cluster 2, patients in cluster 1 exhibited significantly reduced CD4+ T cells, CD8+ T cells, neutrophils, dendritic cells and tumor immune microenvironment scores. Only HHLA2 was more abundant in cluster 1. Moreover, we found that P4HB downregulation could significantly inhibit the colony formation ability and contributed to cell apoptosis of C4-2B and DU145 cell lines. Conclusions: We discovered two new prognostic subtypes associated with immunological dysfunction in PCa patients based on ferroptosis-related genes and found that P4HB downregulation could significantly inhibit the colony formation ability and contributed to cell apoptosis of PCa cell lines.
first_indexed 2024-03-08T09:03:24Z
format Article
id doaj.art-562596ff1f344c9b8e2562544ec17c0d
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-08T09:03:24Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-562596ff1f344c9b8e2562544ec17c0d2024-02-01T06:32:07ZengElsevierHeliyon2405-84402024-01-01101e23495Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patientsDechao Feng0Zhouting Tuo1Jie Wang2Luxia Ye3Dengxiong Li4Ruicheng Wu5Wuran Wei6Yubo Yang7Chi Zhang8Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China; Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China; Corresponding author. Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, ChinaDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, ChinaDepartment of Public Research Platform, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, ChinaDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, ChinaDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, ChinaDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, ChinaDepartment of Urology, Three Gorges Hospital, Chongqing University, Wanzhou, Chongqing, 404000, China; Corresponding author. Department of Urology, Three Gorges Hospital, Chongqing University, Wanzhou, Chongqing, 404000, China.Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China; Corresponding author. Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.Background: We aimed to identify two new prognostic subtypes and create a predictive index for prostate cancer (PCa) patients based on ferroptosis database. Methods: The nonnegative matrix factorization approach was used to identify molecular subtypes. We investigate the differences between cluster 1 and cluster 2 in terms of clinical features, functional pathways, tumour stemness, tumour heterogeneity, gene mutation and tumour immune microenvironment score after identifying the two molecular subtypes. Colony formation assay and flow cytometry assay were performed. Results: The stratification of two clusters was closely connected to BCR-free survival using the nonnegative matrix factorization method, which was validated in the other three datasets. Furthermore, multivariate Cox regression analysis revealed that this classification was an independent risk factor for patients with PCa. Ribosome, aminoacyl tRNA production, oxidative phosphorylation, and Parkinson's disease-related pathways were shown to be highly enriched in cluster 1. In comparison to cluster 2, patients in cluster 1 exhibited significantly reduced CD4+ T cells, CD8+ T cells, neutrophils, dendritic cells and tumor immune microenvironment scores. Only HHLA2 was more abundant in cluster 1. Moreover, we found that P4HB downregulation could significantly inhibit the colony formation ability and contributed to cell apoptosis of C4-2B and DU145 cell lines. Conclusions: We discovered two new prognostic subtypes associated with immunological dysfunction in PCa patients based on ferroptosis-related genes and found that P4HB downregulation could significantly inhibit the colony formation ability and contributed to cell apoptosis of PCa cell lines.http://www.sciencedirect.com/science/article/pii/S2405844023107031Prostate cancerBiochemical recurrenceFerroptosisRadical prostatectomyNonnegative matrix factorizationMolecular subtypes
spellingShingle Dechao Feng
Zhouting Tuo
Jie Wang
Luxia Ye
Dengxiong Li
Ruicheng Wu
Wuran Wei
Yubo Yang
Chi Zhang
Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients
Heliyon
Prostate cancer
Biochemical recurrence
Ferroptosis
Radical prostatectomy
Nonnegative matrix factorization
Molecular subtypes
title Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients
title_full Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients
title_fullStr Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients
title_full_unstemmed Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients
title_short Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients
title_sort establishment of novel ferroptosis related prognostic subtypes correlating with immune dysfunction in prostate cancer patients
topic Prostate cancer
Biochemical recurrence
Ferroptosis
Radical prostatectomy
Nonnegative matrix factorization
Molecular subtypes
url http://www.sciencedirect.com/science/article/pii/S2405844023107031
work_keys_str_mv AT dechaofeng establishmentofnovelferroptosisrelatedprognosticsubtypescorrelatingwithimmunedysfunctioninprostatecancerpatients
AT zhoutingtuo establishmentofnovelferroptosisrelatedprognosticsubtypescorrelatingwithimmunedysfunctioninprostatecancerpatients
AT jiewang establishmentofnovelferroptosisrelatedprognosticsubtypescorrelatingwithimmunedysfunctioninprostatecancerpatients
AT luxiaye establishmentofnovelferroptosisrelatedprognosticsubtypescorrelatingwithimmunedysfunctioninprostatecancerpatients
AT dengxiongli establishmentofnovelferroptosisrelatedprognosticsubtypescorrelatingwithimmunedysfunctioninprostatecancerpatients
AT ruichengwu establishmentofnovelferroptosisrelatedprognosticsubtypescorrelatingwithimmunedysfunctioninprostatecancerpatients
AT wuranwei establishmentofnovelferroptosisrelatedprognosticsubtypescorrelatingwithimmunedysfunctioninprostatecancerpatients
AT yuboyang establishmentofnovelferroptosisrelatedprognosticsubtypescorrelatingwithimmunedysfunctioninprostatecancerpatients
AT chizhang establishmentofnovelferroptosisrelatedprognosticsubtypescorrelatingwithimmunedysfunctioninprostatecancerpatients